|
|
Volumn 33, Issue 3, 2001, Pages 342-345
|
|
Are children with cystic fibrosis who are treated with a proton-pump inhibitor at risk for vitamin B12 deficiency?
a
a
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYANOCOBALAMIN;
HOMOCYSTEINE;
LANSOPRAZOLE;
PROTON PUMP INHIBITOR;
ADOLESCENT;
ARTICLE;
CHILD;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CONTROLLED STUDY;
CORRELATION FUNCTION;
CYANOCOBALAMIN DEFICIENCY;
CYSTIC FIBROSIS;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
PROTEIN BINDING;
RISK ASSESSMENT;
SCHOOL CHILD;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
ADOLESCENT;
CASE-CONTROL STUDIES;
CHILD;
CHILD, PRESCHOOL;
CYSTIC FIBROSIS;
ENZYME INHIBITORS;
FEMALE;
HOMOCYSTEINE;
HUMANS;
MALE;
OMEPRAZOLE;
PROTON PUMPS;
RISK FACTORS;
VITAMIN B 12;
VITAMIN B 12 DEFICIENCY;
|
|
EID: 0034778736
PISSN: 02772116
EISSN: None
Source Type: Journal
DOI: 10.1097/00005176-200109000-00023 Document Type: Article |
|
Times cited : (15)
|
|
References (19)
|
